Drug intelligence / Profile preview

saikosaponin a

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal, Intravenous
01

Overview

Saikosaponin A is a triterpene saponin and one of the main bioactive constituents isolated from the roots of *Bupleurum chinense* (Radix Bupleuri), a traditional medicinal plant widely used in East Asia. It consists of an oleanane-type triterpenoid aglycone linked to carbohydrate moieties[1][2][6]. Pharmacologically, saikosaponin A exhibits diverse biological activities including anti-inflammatory, neuroprotective (notably anticonvulsant and antidepressant), hepatoprotective, immunomodulatory, antiviral and antitumor effects[2][7][9]. Mechanistically, it modulates multiple signaling pathways such as PI3K/Akt/mTOR, MAPK/ERK, JAK/STAT and NF-kB; inhibits N-methyl-D-aspartic acid receptor currents; enhances monoamine neurotransmitter levels; suppresses hippocampal inflammation; reduces oxidative stress; regulates apoptosis-related proteins (e.g., Bcl‑2 family); and influences gut microbiota composition[2][7][9]. Its broad activity profile has made it an object of interest for research into central nervous system disorders (including epilepsy and depression), liver diseases and inflammatory conditions.

Other names
beta-D-Galactopyranoside, (3beta,4alpha,16beta)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl-6-deoxy-3-O-beta-D-glucopyranosyl-
02

Targets

ABCB1 (P-glycoprotein)NMDAR (Glutamate receptor ionotropic, NMDA)MRP (Multidrug resistance-associated protein family)

Beyond the preview

Go deeper on saikosaponin a.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on saikosaponin a.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call